There are 2137 resources available
774P - Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5
Presenter: Kriti Jindal
Session: E-Poster Display
Resources:
Abstract
775P - Whole blood transcriptomic profiling to predict response to immunotherapy in metastatic urothelial cancer
Presenter: Sandra Van Wilpe
Session: E-Poster Display
Resources:
Abstract
776P - Phase II trial of concurrent nivolumab in urothelial bladder cancer with radiation therapy in localized/locally advanced disease for chemotherapy ineligible patients [NUTRA trial]
Presenter: Ulka Vaishampayan
Session: E-Poster Display
Resources:
Abstract
777P - Decrease in derived neutrophil-to-lymphocyte ratio (dNLR) related to immune checkpoint inhibitors (ICI) benefit in patients with metastatic urothelial carcinoma (mUC)
Presenter: Honey Kumar Oberoi
Session: E-Poster Display
Resources:
Abstract
778P - Concomitant antibiotic use and its effect on immune-checkpoint inhibitor efficacy in patients with advanced urothelial carcinoma
Presenter: Mohammad Khan
Session: E-Poster Display
Resources:
Abstract
779P - Validation of prognostic scores in patients with metastatic bladder carcinoma (mBC) enrolled in early phase clinical trials
Presenter: Omar Alhalabi
Session: E-Poster Display
Resources:
Abstract
780P - Cancer susceptibility mutations in Chinese patients with urothelial malignancies
Presenter: Bin Huang
Session: E-Poster Display
Resources:
Abstract
782P - Real-world evidence of the impact of prior autoimmune disease on immune checkpoint inhibitor outcomes in patients with metastatic urothelial cancer
Presenter: Jean Hoffman-Censits
Session: E-Poster Display
Resources:
Abstract
781P - Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab
Presenter: Deniz Tural
Session: E-Poster Display
Resources:
Abstract
783P - Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- (1L) or second-line (2L) PD-1 and PD-L1 inhibitors in the United States (US)
Presenter: Marley Boyd
Session: E-Poster Display
Resources:
Abstract